Go Pro
→ This AI Stock Reminds One Analyst of Early Nvidia (From Brownstone Research) (Ad)tc pixel Free BSPM Stock Alerts
OTCMKTS:BSPM

Biostar Pharmaceuticals (BSPM) Stock Price, News & Analysis

Biostar Pharmaceuticals logo
Compare

About Biostar Pharmaceuticals Stock (OTCMKTS:BSPM)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
43 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biostar Pharmaceuticals, Inc. is a China-based pharmaceutical company that develops, manufactures and markets pharmaceutical products. The company’s activities include the production of prescription and over-the-counter medicines, with offerings that may include chemical drugs and traditional Chinese medicine formulations.

Biostar’s products are intended for distribution through pharmaceutical distributors, hospitals, pharmacies and other healthcare channels in China. The company has focused primarily on serving the domestic Chinese healthcare market rather than operating as a broadly international pharmaceutical business.

Publicly available information about Biostar Pharmaceuticals’ current operations, product portfolio and leadership is limited. Accordingly, specific product and executive details may change and should be verified through the company’s latest public disclosures.

AI Generated. May Contain Errors.

Receive BSPM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biostar Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BSPM Stock News Headlines

Beijing Biostar Pharmaceuticals Co. Ltd.
April 5, 2026  |  wsj.comhttps://www.wsj.com/market-data/quotes/HK/2563
Biostar Pharma Successively Achieved First Patient Dosing for Two Phase II/III Multiregional Clinical Trials of Utidelone Capsule (UTD2)
September 15, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/biostar-pharma-successively-achieved-first-120000694.html
October 7th dollar deadline
Former hedge fund manager Larry Benedict called the 2020 market drop and the 2022 downturn before they happened. Now he's pointing to October 7 as a critical date for the US dollar. He says a federal deadline on that day could hit some of the biggest AI stock winners, with gains potentially cut by as much as 40 percent. Benedict is hosting a free briefing to walk through a three-step approach he believes could help investors prepare.tc pixel
September 26 at 1:00 AM  |  Brownstone Research (Ad)
Biostar Pharmaceuticals Inc (BSPM)
April 24, 2025  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/bspm
Biostar Pharma Announces First Patient Enrolled for Phase 1 Study of Utidelone Capsule (UTD2)--The World's First Oral Epothilone Anti-Cancer Drug
June 12, 2023  |  benzinga.comhttps://www.benzinga.com/pressreleases/23/06/n32815859/biostar-pharma-announces-first-patient-enrolled-for-phase-1-study-of-utidelone-capsule-utd2-the-wo
BioCryst Pharmaceuticals Stock Down 20% After Wider 4Q Loss Reported
February 23, 2023  |  marketwatch.comhttps://www.marketwatch.com/story/biocryst-pharmaceuticals-stock-down-20-after-wider-4q-loss-reported-e336007e
Biostar Pharmaceuticals, Inc. (BSPM)
August 14, 2022  |  finance.yahoo.comhttps://finance.yahoo.com/quote/BSPM/history
Biostar launches new mining rig with 8 graphics cards
April 28, 2022  |  msn.comhttps://www.msn.com/en-us/sports/esports/biostar-launches-new-mining-rig-with-8-graphics-cards/ar-AAWH1TC
See More Headlines

BSPM Stock Analysis - Frequently Asked Questions

Biostar Pharmaceuticals, Inc. (OTCMKTS:BSPM) issued its quarterly earnings data on Wednesday, November, 15th. The company reported ($0.50) earnings per share for the quarter.

Shares of BSPM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biostar Pharmaceuticals investors own include Cellectar Biosciences (CLRB), HudBay Minerals (HBM), Baytex Energy (BTE), Cyclacel Pharmaceuticals (CYCC) and

Company Calendar

Last Earnings
11/15/2017
Today
9/26/2026
Fiscal Year End
12/31/2026
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:BSPM
CIK
N/A
Web
biostarpharmaceuticals.com
Phone
862933686638
Fax
N/A
Employees
200
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
75.79
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (OTCMKTS:BSPM) was last updated on 9/26/2026 by MarketBeat.com Staff.
From Our Partners
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
I'm giving you a space stock today. Free.
On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...
Behind the Markets | Sponsoredtc pixel
"How Much Can I Actually Spend Each Year With $2.5M Saved?"
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...
SmartAsset | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Why This Small AI Company Holds 150 Patents
Jeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...
Brownstone Research | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
6 Elon Musk companies. The 1 FREE investor roadmap to them all.
Elon Musk owns six companies, but most investors can only access four. Tesla, SpaceX, xAI, and X are public an...
Zacks | Sponsoredtc pixel